News
Among these, the ITR1 form, more commonly called Sahaj, holds significance. Widely utilized across India, this form of ITR-1 for salaried employees is one of the most prevalent. As a straightforward ...
Aurobindo Pharma's Bone Treatment Drug Shows Promise in Tests Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has announced successful trial results for its new bone treatment medicine. The drug, ...
CRANBURY, NJ, USA I March 28, 2025 I Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of ...
BioNTech is running or planning phase 1/2 trials to show whether BNT327 pairs well with TROP2, HER2, HER3 and B7H3 antibody-drug conjugates, and its longer-term road map includes studies with ...
and lean protein Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND): This diet aims to lower the risk of dementia, focusing on whole grains, green leafy vegetables, berries ...
Designed to test VLP Peanut’s safety and tolerability, the PROTECT phase 1 trial is the first study of the vaccine in human beings, including 12 adults with peanut allergy and 12 adults with no ...
The Chief Minister also revealed that infrastructure projects worth ₹1 lakh crore are slated for completion this year, marking a transformative phase for Maharashtra’s development landscape.
The Rahmani Mission Saturday March 22, 2025 announced the Rahmani 30 Entrance Test 2025 Phase 1 result on its official website 'rahmanimission.info' Rahmani 30: The Rahmani Mission Saturday March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results